Moderna Shares Surge Over 12% on Melanoma Vaccine Data and Upcoming Pipeline Updates

SentiSense · Published Sep 21, 2026, 11:45 AM ET · Updated Sep 22, 2026, 8:05 AM ET

Moderna rose 12.27% on September 21, 2026, touching a 52-week high of $176.75, after its Phase 3 INTerpath-001 melanoma study with Merck's Keytruda wo...